| [1] |
.Clin Cancer Res，2008，14（14）：4491-4499.
|
| [2] |
Wo XD，Hong XQ，Gao CX，et al.Long-period virulent test of curcumin［J］.J Zhejiang Tradit Chin Med Coll （浙江中医学院学报），2000，24（1）：61-65.
|
| [3] |
Wo XD，Hong XQ，Gao CX.Maximum toleration test of curcumin［J］.J Zhejiang Tradit Chin Med Coll （浙江中医学院学报），2000，24（2）：55-55.
|
| [4] |
Sharma RA，McLelland HR，Hill KA，et al.Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer［J］.Clin Cancer Res，2001，7（7）：1894-1900.
|
| [5] |
Lao CD，Ruffin MT，Normolle D，et al.Dose escalation of a curcuminoid formulation［J］.BMC Complement Altern Med，2006，6：10.
|
| [6] |
Cheng AL，Hsu CH，Lin JK，et al.Phase I clinical trial of curcumin，a chemopreventive agent，in patients with high-risk or pre-malignant lesions［J］.Anticancer Res，2001，21（4b）：2895-2900.
|
| [7] |
T?nnesen HH，Másson M，Loftsson T.Studies of curcumin and curcuminoids.XXVII.Cyclodextrin complexation：solubility，chemical and photochemical stability［J］.Int J Pharm，2002，244（1/2）：127-135.
|
| [8] |
Khan MA.Enhancement of solubility of poorly water soluble drugs diclofenac Sodium by mixed solvency approach［J］.Res J Pharm Dosage Form Technol，2013，5（1）：39-41.
|
| [9] |
Millard J，Alvarez-Nú?ez F，Yalkowsky S.Solubilization by cosolvents.Establishing useful constants for the log-linear model［J］.Int J Pharm，2002，245（1/2）：153-166.
|
| [10] |
Gupta NK，Dixit VK.Bioavailability enhancement of curcumin by complexation with phosphatidyl choline［J］.J Pharm Sci，2011，100（5）：1987-1995.
|
| [11] |
Shulman M，Cohen M，Soto-Gutierrez A，et al.Enhancement of naringenin bioavailability by complexation with hydroxypropyl-β-cyclodextrin.［corrected］［J］.PLoS One，2011，6（4）：e18033.
|
| [12] |
Ko?bia? M，Gierycz P.Comparison of aqueous and 1-octanol solubility as well as liquid-liquid distribution of acyclovir derivatives and their complexes with hydroxypropyl-β-cyclodextrin［J］.J Solution Chem，2013，42（4）：866-881.
|
| [13] |
Serajuddin AT.Salt formation to improve drug solubility［J］.Adv Drug Deliv Rev，2007，59（7）：603-616.
|
| [14] |
Liversidge GG，Cundy KC.Particle size reduction for improvement of oral bioavailability of hydrophobic drugs：I.Absolute oral bioavailability of nanocrystalline danazol in beagle dogs［J］.Int J Pharm，1995，125（1）：91-97.
|
| [15] |
Rao S，Song Y，Peddie F，et al.Particle size reduction to the nanometer range：a promising approach to improve buccal absorption of poorly water-soluble drugs［J］.Int J Nanomedicine，2011，6：1245-1251.
|
| [16] |
Sigfridsson K，Lundqvist AJ，Strimfors M.Particle size reduction for improvement of oral absorption of the poorly soluble drug UG558 in rats during early development［J］.Drug Dev Ind Pharm，2009，35（12）：1479-1486.
|
| [17] |
Liversidge GG，Conzentino P.Drug particle size reduction for decreasing gastric irritancy and enhancing absorption of naproxen in rats［J］.Int J Pharm，1995，125（2）：309-313.
|
| [18] |
Zhou XY，Lin HQ，Lei W.Research progress of insoluble drug nanocrystals［J］.Cent South Pharm （中南药学），2013，11（5）：353-358.
|
| [19] |
Yue PF，Liu Y，Xie J，et al.Review and prospect on preparation technology of drug nanocrystals in the past thirty years［J］.Acta Pharm Sin （药学学报），2018，53（4）：529-537.
|
| [20] |
Peltonen L，Hirvonen J.Pharmaceutical nanocrystals by nanomilling：critical process parameters，particle fracturing and stabilization methods［J］.J Pharm Pharmacol，2010，62（11）：1569-1579.
|
| [21] |
Chang TL，Zhan HL，Liang DN，et al.Nanocrystal technology for drug formulation and delivery［J］.Front Chem Sci Eng，2015，9（1）：1-14.
|
| [22] |
Yu WB，Jin ZM，Jian YF，et al.The pharmacokinetics of curcumin extract and turmeric monomer after administration in rats［J］.Pharmacol Clin Chin Mater Med （中药药理与临床），2018，34（5）：30-33.
|
下载:
